EMEA-000828-PIP05-17
Key facts
| Invented name |
Jardiance
|
| Active substance |
empagliflozin
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0216/2017
|
| PIP number |
EMEA-000828-PIP05-17
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Prevention of cardiovascular events in patients with chronic heart failure
|
| Route(s) of administration |
Oral use
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|